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ABSTRACT  We previously showed (Frace, A. M. and H. C. Hartzell. 1993.Journal 
of Physiology. 472:305-326)  that internal perfusion of frog atrial myocytes with the 
nonselective  protein  phosphatase  inhibitors  microcystin  or  okadaic  acid  pro- 
duced an increase in the L-type Ca current (/ca) and a decrease in the delayed rec- 
tifier K  current  (IK). We hypothesized that microcystin revealed the activity of a 
protein kinase  (PKX)  that was basally active in  the  cardiac myocyte that  could 
phosphorylate the Ca and K channels or regulators of the channels. The present 
studies were aimed at determining the nature of PKX and its phosphorylation tar- 
get. The effect of internal perfusion with microcystin on /Ca or I K was not attenu- 
ated by inhibitors of protein kinase A  (PKA). However, the effect of microcystin 
on Ica was largely blocked by the nonselective protein kinase inhibitors staurospo- 
rine (10-30 nM), K252a  (250 nM), and H-7 (10 I,M). Staurosporine and H-7 also 
decreased the stimulation of Ica by isoproterenol, but K252a was more selective 
and blocked the ability of microcystin to stimulate Ica without significantly reduc- 
ing isoproterenol-stimulated current.  Internal perfusion with selective inhibitors 
of protein  kinase  C  (PKC),  including the  autoinhibitory pseudosubstrate  PKC 
peptide  (PKC~xg-~a/) and a  myristoylated derivative of this peptide had no effect. 
External application of several PKC inhibitors had negative side effects that pre- 
vented their use as selective PKC inhibitors. Nevertheless, we conclude that PKX is 
not PKC. PKA and PKX phosphorylate sites with different sensitivities to the phos- 
phatase inhibitors calyculin A and microcystin. In contrast to the results with Ica, 
the  effect of microcystin on  IK was  not blocked by any of the  kinase inhibitors 
tested, suggesting that the effect of microcystin on IK may not be mediated by a 
protein kinase but may be due to a direct effect of microcystin on the IK channel. 
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INTRODUCTION 
The L-type Ca current (/ca) plays a key role in excitation-contraction coupling in 
the heart and is one of the most important targets for the autonomic neurotrans- 
mitters that regulate the force of cardiac contraction  (Hartzell and Duchatelle- 
Gourdon, 1992). Stimulation of [3-adrenergic  receptors increases Ic~ by stimulating 
cAMP-dependent phosphorylation via the Gcadenylyl cyclase-cAMP-cAMP depen- 
dent protein kinase cascade (Hartzell, 1988; Trautwein and Hescheler, 1990). Mus- 
carinic acetylcholine receptors antagonize the effects of [3-adrenergic  receptors by 
inhibiting cAMP  synthesis in  a  Gi-dependent manner.  The  involvement of the 
cAMP-dependent phosphorylation pathway in effecting the action of [3-adrenergic 
receptors has been well established by experiments showing that [3-receptors stimu- 
late adenylyl cyclase and cAMP-dependent protein kinase (PKA), that forskolin (a 
direct stimulator of adenylyl cyclase), exogenous cAMP, and exogenous catalytic 
subunit of cyclic AMP dependent protein kinase mimic the effects of [3-adrenergic 
agonists, and that inhibitors of PKA completely inhibit the effects of B-adrenergic 
agonists on Ic,. 
Despite the considerable evidence for the involvement of cAMP-dependent phos- 
phorylation in regulation of Ic~, there remain a  number of questions  (Hartzell, 
1993). First, it is unclear whether the ~1 subunit of the Ca channel is the final target 
for cAMP-dependent phosphorylation or whether there are  other intermediates 
(possibly other subunits of the Ca channel) between the phosphorylated substrate 
and the Ca channel itself. Secondly, there is evidence to suggest that the Ca chan- 
nel may be regulated by other mechanisms in addition to cAMP-dependent phos- 
phorylation. For example, it has been proposed that the Ca channel may be regu- 
lated directly by Gs0~ (Brown and Birnbaumer, 1990), although this remains contro- 
versial  (Hartzell and Fischmeister, 1992).  In addition, the Ca channel is regulated 
by protein kinase C  (Lacerda, Rampe, and Brown,  1988; Walsh, Begenisich, and 
Kass, 1989; Singer-Lahat, Gershon, Lotan, Hullin, Biel, Flockerzi, Hofmann, and 
Dascal,  1992) and this phosphorylation has been suggested to mediate the effects 
of angiotensin II (D6semeci, Dhallan, Cohen, Lederer, and Rogers, 1988) and pos- 
sibly al adrenergic agonists as well, although this is less certain (Dirksen and Sheu, 
1990). 
Recently, we showed that nonselective protein phosphatase inhibitors, such as 
okadaic acid and microcystin, in the absence of [3-adrenergic  stimulation, cause a 
large increase in/Ca and a decrease in the delayed rectifier K current, IK (Frace and 
Hartzell, 1993). The kinase(s) responsible for these effects were not identified, al- 
though we did show that the increase in/Ca was  likely to be caused by phosphoryla- 
tion because the effect was dependent upon intracellular ATP. The purpose of the 
present experiments was to determine the nature of the protein kinase revealed by 
protein phosphatase inhibition and to determine whether this protein kinase has a 
physiological role in the regulation of the Ca or K currents. 
METHODS 
Cell isolation  and electrophysiological  techniques  have been described in detail previously  (Fisch- 
meister and Hartzell, 1986; Duchatelle-Gourdon  et al., 1989; Hartzell et al., 1991). Briefly,  frog HARTZELL ET AL.  Two Phosphorylation  Sites Regulate Ca Current  395 
(Rana catesbiana) ventricular and atrial cells were enzymatically isolated and patch clamped by the 
whole-cell patch clamp technique. Internal solution for recording/ca from ventricular cells was 
(in  millimolar)  118  CsC1, 4  MgC12, 2.8  Na2K~ATP, 10  K2PIPES,  5  Na-creatine phosphate,  5 
K2EGTA, pH to 7.15 with KOH. For recording I~ and Ic~ from atrial cells the internal solution con- 
tained 118 KCI, 4 MgC12, 2.8 Na2K,2ATP, 10 K2PIPES, 5 Na-creadne phosphate, 5 KzEGTA, pH to 
7.15 with KOH. Various test compounds were applied internally  via pipet perfusion. External solu- 
tion for ventricular cells was 103 NaC1, 20 CsC1, 10 HEPES, 1.8 CaCI2, 1.8 MgC12, 5 pyruvic acid, 5 
D-glucose, 0.3 IxM tetrodotoxin, pH to 7.4 with NaOH. External solution for atrial cells replaced 
CsC1 with NaC1 and contained, in addition, 2.5 mM KC1. All experiments were conducted at room 
temperature. Cells were patch clamped with borosilicate patch pipets having resistances of 1-2 
MII. Total series resistance was usually <3 MI). Ica and IK were elicited at various frequencies by 
voltage pulses delivered by a programmable digital stimulator (Challenger DB, W. Goolsby, Ki- 
netic Software and Emory University, Atlanta, GA). Routine pulses were from -80 mV holding po- 
tential to 0 or to +20 inV. In ventricular cells, the pulse was 200-400 ms in duration and Ica was 
measured as the peak inward current minus the current at the end of the pulse. In atrial cell ex- 
periments,/ca was measured by subtracting the current at 200 ms from the peak inward current 
and IK was measured by subtracting the current at 200 ms from the outward current at the end of 
a 10-20-s duration pulse. 
Reagents included cAMP-dependent protein kinase inhibitor peptide, PKI(5-22)  [TTYADFIAS- 
GRTGRRNAIHD-NH2]  (Promega  Corp.,  Madison, WI); microcystin-LR [cyclo-(n-alanine)-(L-leu- 
cine  )-  (  D-erythro-~-methylaspartic  acid)-  (L-arginine)-  (3-amino-9-methoxy-2,6,8-trimethyl-10-phenyl- 
deca-4,6-dienoic acid)-(D-glutamic acid)-(N-methyldehydroalanine)] (GIBCO BRL, Gaithersburg, 
MD); H-7 [(_+)-1 (5-isoquinolinesulfonyl)-2-methylpiperazine  dihydrochloride) (LC Laboratories, 
Woburn, MA); protein kinase C autoinhibitory peptide, PKC(19_~l) [RFARKGALRQKNV]  (LC Lab- 
oratories);  mytistoytated  protein  kinase  C  autoinhibitory  peptide  [myr-RFARKGALRQKNV] 
(Promega  Corp.);  adenosine  cyclic 3',5'-(Rp)-phosphorothioate  (provided by Dr.  Ira  Cohen, 
SUNY, Stony Brook, NY); K252a  (Calbiochem Corp., LaJolla, CA); staurospotine  (Calbiochem 
Corp.); calphostin C (LC Laboratories); forskolin (Calbiochem Corp.); calyculin A (LC Laborato- 
ties); acetylcholine (Sigma Chemical Co., St. Louis, MO). Stock solutions of staurospotine, K252a, 
and calphostin C were prepared at 1 mM in DMSO. Microcystin was made 0.5 mM in 10% metha- 
nol. Other peptides were dissolved in water at 1-5 mM.  Forskolin was 10 mM in 100% ethanol. 
Acetylcholine was 1 M in 0.1 mM HCI. Stock solutions were stored at -20~ 
RESULTS 
PKA Inhibition Has No Effect on Responses to Microcystin 
Fig. 1 A is a control experiment showing the effect of internal perfusion with micro- 
cystin on/Ca and IK in a frog atrial myocyte. In this experiment, the cell was first ex- 
posed  to  10  txM  forskolin,  which  increased  /ca  ~16-fold  and  IK ~2.5-fold.  After 
washing out forskolin, the cell was perfused internally with  10  jxM microcystin-LR 
(Rinehart, Harada, Namikoshi, Chen, and Harvis, 1988; Honkanen, Zwiller, Moore, 
Daily, Khatra, Dukelow, and Boynton,  1990; MacKintosh, Beattie, Klumpp, Cohen, 
and Codd,  1990). This resulted in a  ~10-fold increase in Ic~ and a  ~50%  decrease 
in IK. As we have published previously (Frace and Hartzell, 1993), microcystin does 
not change the shape of the LVcurve for TCa or the steady state activation curve for 
IK. The effect of microcystin is to increase/Ca and decrease IK at all potentials where 
these  currents  are  activated. Although  microcystin  affects/ca  and  IK with  similar 
time courses in Fig. 1 A, the effect of microcystin on IK was frequently more rapid 396  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  ￿9  VOLUME  106  .  1995 
than the effect on Ica. This is illustrated for an extreme  example in Fig.  1 B.  This 
cell was perfused with 20/xM  microcystin, and the subsequent change in IK and/(:~ 
were fitted to single exponentials. The decrease in IK occurred with a T =  1.06 min, 
whereas the effect on Ic.~ occurred with a "r =  10.4 min. In four cells where we fitted 
the change in current amplitude to exponentials,  IK decreased with -r =  2.5  +  0.6 
rain and Ic~ increased with a "r =  7.5  +  1.9 min. 
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FIGURE 1.  Effect of a PKA inhibitor on response to microcystin in frog atrial myocytes. (A) Control 
effect of microcystin on/c:~ and I~. A  patch-clamped atrial myocyte was stimulated once ever), 30 s 
with 10-s duration  pulses to 0  mV from a  holding potential of -80  inV./c~ (open squares)  was mea- 
sured as the difference between peak inward current and current at 200 ms. Ik (open triangles)  was 
measured as outward current at the end of the pulse minus the current at 200 ms. Holding current 
(open circles) was measured at -80  inV. 10 ixM forskolin was applied to the superfusion during the 
bar. After forskolin was washed out,  10 ixM microcystin-LR was applied by internal perfusion. Inter- 
nal perfusion was begun at the time indicated, but measurements with fluorescent dyes showed that 
1-5 min was required for the new solution to reach the tip of the pipette depending on the flow rate 
of the internal perfusion system and the proximity of the internal capillary to the pipette tip. Repre- 
sentative current traces are shown for control, forskolin, and microcystin. Although it appears that 
the activation kinetics of IK are accelerated by microcystin, this is not a consistent observation. Often, 
such acceleration is observed spontaneously during the course of an experiment without any drug 
exposure.  (B) Time course of the effect of microcystin on/~:, and IK. A cell was perfused internally 
with 20 IxM microcystin as in A. The record shown begins with the first current that is different from 
basal after adding microcystin to the internal perfusion. The changes in current amplitudes were fit- 
ted to single exponentials. (C) Effect of 50 IxM PKIIs_~z  ) on the response to 20 IxM microcystin and 10 
IxM forskolin. The effect of forskolin is inhibited, whereas the response to microcystin is unaffected. HARTZELL ET AL.  Two Phosphorylation  Sites Regulate  Ca Current  397 
Fig. 1 C shows that neither the effect on  /Ca nor the effect on Is was mediated by 
phosphorylation catalyzed by PKA, because internal perfusion with 50 wM PKI(5-22) 
(Cheng, Kemp, Pearson, Smith, Misconi, VanPatten, and Walsh,  1986)  did not af- 
fect the response to microcystin. As a positive control to show that PKI(5-22) actually 
inhibited PKA, we show in Fig. 1 C that the response to 10 o~M forskolin is blocked 
by  this  inhibitor.  These  results  confirm  our  previous  preliminary  conclusions 
(Frace and Hartzell, 1993) and show clearly that the changes in/Ca and IK produced 
by microcystin are not due to inhibition of dephosphorylation of a site phosphory- 
lated by PKA. For convenience, the presumptive protein kinase responsible for the 
microcystin effect is termed PKX. 
Staurosporine Blocks the Effect of Microcystin on Ic,, 
We screened several protein kinase inhibitors to determine their ability to block 
the effects of microcystin. Initially, we examined the effect of these inhibitors only 
on  /Ca in ventricular myocytes. Both staurosporine  (Tamaoki, Nomoto, Takahashi, 
Kato, Morimoto, and Tomita,  1986; Rfiegg and Burgess,  1989)  and K252a  (Kase, 
Iwahashi,  Nakanishi,  Matsuda, Yamada,  Takahashi,  Murakata,  Sato,  and Kaneko, 
1987; Rflegg and Burgess, 1989) were able to block the effect of microcystin on/ca. 
Fig. 2 illustrates the effects of staurosporine. Staurosporine was applied extracellu- 
larly at concentrations between 3 and 100 nM before internal perfusion with micro- 
cystin was begun. At concentrations />30 nM, staurosporine almost completely at- 
tenuated the increase in/ca produced by microcystin (Fig. 2 A). On average, in the 
presence of 30 nM  staurosporine,  microcystin increased /ca only 0.97  +-  0.4-fold 
(n =  3)  compared to a normal 10.9  +  1.0-fold (n =  6)  increase in the absence of 
staurosporine. Even though 30 nM staurosporine nearly completely blocked the re- 
sponse to microcystin, subsequent exposure to Iso  (with 30 nM staurosporine out- 
side and 10 p~M microcystin inside) stimulated/Ca 10.0 -+- 3.3-fold (n =  3). This level 
of stimulation was somewhat less than the 19.4 -+ 2.2-fold (n =  4)  increase in cur- 
rent produced by Iso and microcystin together in the absence of staurosporine. It 
should be noted that fold changes  cited in  the  text are derived from measuring 
changes  in current amplitudes  in  response to an  intervention in individual  cells 
and then computing the average. This "average change" (cited in the text) usually 
differs somewhat from the difference between "average current densities" (plotted 
in the figures) under different conditions. Fig. 2 A also shows that/ca is irreversibly 
stimulated by Iso in the presence of microcystin. When  Iso is washed out,  ICa  re- 
mains elevated for at least 5 min. A similar example is shown in Fig. 5 B, although 
in this case,/Ca did decrease a small amount over a 10-min time period. 
The experiment of Fig. 2 A suggested that staurosporine inhibits the protein ki- 
nase that is responsible for stimulation of Ic~ by microcystin but has only a small ef- 
fect on PKA. This conclusion is surprising considering that staurosporine has been 
shown  to  inhibit  PKA  at  these  concentrations.  However,  this  interpretation  re- 
quires circumspection for the following reason. If PKA activity is not completely in- 
hibited by staurosporine, the fraction that remains active could be sufficient to in- 
crease /ca,  because every phosphorylated substrate  molecule will be "trapped" in 
the phosphorylated state as a  result of inhibition of the protein phosphatase.  For 
this reason, to compare the selectivity of staurosporine for PKA and PKX it was nec- 398  THE JOURNAL OF GENERAL PHYSIOLOGY  -  VOLUME  106  ￿9  1995 
essary to examine the effect of staurosporine on the Iso response in the absence of 
phosphatase inhibitors. Fig. 2  B shows that in the absence of microcystin, stauro- 
sporine produced a  dose-dependent inhibition of the  Iso response.  The  ICs0  for 
the effect of staurosporine on Iso-stimulated/c~ was  12 nM (shown qualitatively in 
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FIGURE 2.  Effect of staurosporine on response to microcystin in frog ventricular myocyte. (A-C) 
Patch clamp records obtained as described in Fig. 1, legend. Holding current: open circles. I(~: open 
squares.  30 nM staurosporine and 1 IxM isoproterenol were applied by superfusion and microcystin 
was applied by internal perfusion during the times indicated. (A) Effect of microcystin and isopro- 
terenol on/(:~ after exposure to staurosporine. (B) Effect of staurosporine on I(:~ previously stimu- 
lated by isoproterenol. (C) Effect of staurosporine on/ca previously stimulated by microcystin. (D) 
Summary of the effect of staurosporine on/ca. Current densities are plotted for control conditions 
(open bars)  and after exposure to 10 nM staurosporine (hatched bars)  or 30 nM staurosporine (cross- 
hatched bars). Basal current was measured before exposure to any other drug. The Iso columns were 
obtained by first stimulating/ca  with Iso and then sequentially  testing the responses to different con- 
centrations ofstaurosporine as in Fig. 2 B. The microcystin (MC) and microcystin + Iso (MC+ISO) 
columns were obtained by first exposing the cell to staurosporine and then testing the effect of mi- 
crocystin and microcystin plus Iso as in Fig. 2 A. Means are averages of 4-18 cells. 
Fig. 2 D,  but quantitative data not shown)￿9 Quantitative analysis of dose-response 
curves such as the one in Fig. 2 B were slightly compromised by the slow effect of 
staurosporine and failure to reach a  true steady state, even after 10 min staurospo- 
rine exposure.  Nevertheless, we  estimate  that  the  error introduced by failure to HARTZELL ET AL.  Two Phosphorylation Sites Regulate Ca Current  399 
reach true steady state is < 10%. These data show clearly that the potency of stauro- 
sporine to inhibit stimulation of/ca by either Iso alone or microcystin is similar. In 
contrast, staurosporine has little effect on the ability of Iso to stimulate the current 
in the presence of microcystin. 
Our interpretation of the experiments of Fig. 2, A and B, were based on the as- 
sumption  that staurosporine was inhibiting microcystin- and Iso-stimulated Ic~ by 
inhibiting a protein kinase. To test whether staurosporine might have other, possi- 
bly direct effects on the Ca channel, we examined the effect of staurosporine on/ca 
previously elevated by microcystin. We reasoned that after microcystin had com- 
pletely inhibited phosphatase activity and all the substrate was phosphorylated, in- 
hibition of the protein kinase would have no effect. In Fig. 2  C, staurosporine was 
applied somewhat before the effect of microcysfin was complete. This application 
of staurosporine arrested the continuing increase in Ic~, but did not reduce/ca be- 
low the level that had already been stimulated by microcystin. This result shows that 
staurosporine does not inhibit microcystin stimulation of/Ca by acting directly on 
the Ca channel, for example. 
The effects of staurosporine are summarized in Fig. 2 D. Staurosporine at both 10 
and  30  nM  significantly reduced  the  stimulation  of /Ca  by microcystin  and  de- 
creased/Ca previously elevated by Iso. These data show that staurosporine does not 
selectively inhibit PKX over PKA. Staurosporine also reduced basal/Ca. On average, 
30 nM staurosporine reduced basal Ica 44 -L-_ 10%  (n =  3). This decrease was not 
due to rundown, because in most cells/ca increased during the first 20 min of the 
experiment. 
K252a Selectively Blocks the Effect of Microcystin on Ica 
The  protein  kinase  inhibitor  K252a,  which  is  closely  related  to  staurosporine 
(Rfiegg and Burgess,  1989), was more selective in inhibiting microcystin stimula- 
tion of/Ca than was staurosporine. In Fig. 3 A, 250 nM K252a inhibited Iso stimu- 
lated Ica only ~30%, but strongly inhibited the stimulation produced by microcys- 
tin. On average, Iso-sfimulated/Ca was reduced only 18 -  11%  (n =  4) by 250 nM 
K252a,  whereas  microcystin-stimulation of Ic~ was  reduced  70%.  Like staurospo- 
fine, K252a had much less effect on the response to Iso in the presence of micro- 
cystin (Fig. 3, A and B) and caused a 37 +- 16% (n =  4) decrease in basal Ic~ (Figs. 3 
B and 4 A). 
Staurosporine and K252a Do Not Block Effect of Microcystin on Ix 
The next question was whether the parallel decrease in IK caused by microcystin 
was also due to the same protein kinase that increased Ica. Fig. 4 A shows that 250 
nM K252a did not inhibit the effect of internal perfusion with microcystin on IK in 
an atrial cell. Internal perfusion with microcystin in the presence of K252a caused a 
~60% decrease in IK, even though stimulation of Ic~ was largely inhibited. On aver- 
age, 20 ~M microcystin produced a  somewhat greater decrease in IK in the pres- 
ence of K252a than under control conditions (Fig. 4 ~). Thus, the effect of micro- 
cystin on IK could be due to the action of a protein kinase that is not inhibited by 
K252a or might be due to another (possibly direct) effect of microcystin on IK. We 
prefer the hypothesis that the decrease in IK produced by microcystin is not medi- 400 
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FIGURE 3.  Effect  of K252a  on 
response of Ic~ to microcystin  in 
frog  ventricular  myocytes.  (A) 
Patch  clamp  record.  250  nM 
K252a and 1 fxM lso were applied 
by superfusion and 20 p~M micro- 
cystin  was  applied  by  internal 
perfusion during the periods in- 
dicated.  (Open circles) Holding 
current.  (Open squares) h:a. (B) 
Summary of effects of K252a on 
Ica in  ventricular  myocytes.  See 
Fig.  2 D for details.  (Open ba~) 
Control.  (Hatched bars) 250  nM 
K252a. Means are averages of 4-8 
cells. 
ated by the action of a protein kinase, because we have not been unable to identify 
any protein kinase inhibitor that reduces the effect of microcystin on I~. For exam- 
ple, microcystin also reduced I~ at least 40%  in the presence of 100 nM staurospo- 
rine  (Fig. 4 B), which did inhibit the response of Ica to Iso or microcystin (Fig. 2, A 
and B). The effects of K252a in atrial cells are summarized for/Ca in Fig. 4, C and D 
and for IK in Fig. 4, E and F. The effects of K252a on/ca are very similar in atrial and 
ventricular cells  (compare Fig. 3 B with Fig. 4,  C and D). However, K252a has little 
or no effect on the ability of microcystin to inhibit IK (Fig. 4, E and f). HARTZELL ET AL.  Two Phosphorylation  Sites Regulate Ca Current  401 
FIGURE 4.  Effect of K252a and staurosporine on response of Ic~ and IK to microcystin in frog atrial 
myocytes. (A) Patch clamp record showing inhibition  of IK by microcystin in the presence of K252a. 
250 nM K252a and 1 p,M Iso were applied via superfusion and 20 ~M microcystin was applied by in- 
ternal perfusion during the periods indicated. (Open squares) Ica.( Open triangles) &.  (Open circles) 
Holding current. (B) Patch clamp record as in A showing inhibition  oflK by microcystin in the pres- 
ence of 100 nM staurosporine. (C) Summary of effects of K252a on Ic, current density in atrial myo- 
cytes. (D) Data in Cexpressed as relative Ca current. For each individual cell analyzed in C, relative 
/c~ was calculated by dividing /ca in the presence of 250 nM K252a (K252a), 20 ~M microcystin 
(MC), and 20 ~M microcystin plus 250 nM K252a (MC+K252a)  by the control basal Ic~. Thus, these 
values reflect  the real changes occurring in /ca, amplitude with different treatments in individual 
cells, whereas the data in C plots only Ca current density. Similar conclusions are obtained from the 
two methods, but the numbers differ slightly. (E) Summary of effects of K252a on IK density in atrial 
myocytes. (P) Data in Eexpressed as relative IK as described in D. Means are averages of 4-14 cells. 
Does Microcystin Stimulate Ic~ via Protein Kinase C? 
Staurosporine and K252a are both relatively nonselective protein kinase inhibitors, 
but they both inhibit protein kinase C  in vitro at submicromolar concentrations 
(R/iegg and Burgess, 1989). To determine whether the stimulation of Ic~ by micro- 
cystin was due to protein kinase C, we examined the effects of several selective pro- 
tein kinase C inhibitors. 402  THE JOURNAL  OF  GENERAL  PHYSIOLOGY  ￿9  VOLUME  106  .  1995 
In our previous paper (Frace and Hartzell, 1993), we reported, but did not show, 
that a pseudosubstrate PKC peptide fragment (PKC(19-361) had no effect on the stim- 
ulation of/ca by microcystin. In the present series of experiments, we found that an- 
other pseudosubstrate PKC inhibitor (PKC(19_31)) (House and Kemp, 1990) applied 
by internal perfusion at concentrations of 20 txM had no effect on the response to 
20  IxM  microcystin. A  myristoylated derivative  of this  inhibitor  (myr-PKC/19_~l)), 
which has been reported to be a  more effective inhibitor of PKC because it is tar- 
geted to the membrane  (Eichholtz, deBont, deWidt, Liskamp, and Ploegh,  1993), 
also had no effect when applied internally at concentrations of 100 IxM  (Fig. 5 A). 
This myristoylated PKC inhibitor has also been reported to be an effective PKC in- 
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FIGURE 5.  Effects of a PKC in- 
hibitor and BAPTA on the effect 
of microcystin on Ic, in ventricu- 
lar myocytes. (Open  squares) Ica. 
(Open  circles) Holding  current. 
(A) Patch clamp record showing 
lack of effect  of a  myristoylated 
derivative of PKC~I~.~I) on the re- 
sponse of Ica to microcystin.  100 
IxM myr-PKC(19_31)  and 10 txM mi- 
crocystin  were  applied by inter- 
nal perfusion and Iso was applied 
by superfusion during periods in- 
dicated.  (B). Patch clamp record 
showing effect of microcystin  in 
the presence of an internal solu- 
tion containing BAPTA. 5  mM 
BAPTA was  added  to  the  stan- 
dard internal solution (Methods) 
from  the  onset  of  the  experi- 
ment. The cell was  depolarized 
by 200-ms pulses  to 0 mV once 
every, minute. 20 IxM microcystin 
was applied by internal perfusion 
and Iso was applied by superfu- 
sion during periods indicated. HARTZELL ET AL.  Two Phosphorylation Sites Regulate Ca Current  403 
hibitor when applied externally. Applied externally,  this inhibitor completely and 
rapidly blocked the basal Ca current at concentrations >1 IzM (not shown). We be- 
lieve that this block was not associated with protein kinase inhibition for the follow- 
ing reasons. (a) The block was usually associated with a significant increase in hold- 
ing current.  (b)  The block was very rapid in onset and was also rapidly reversible 
(complete within several seconds). This seems too fast to be mediated by kinase- 
phosphatase  mechanisms.  (c)  Externally-applied  1  ~M  myr-PKC~l~311 rapidly and 
reversibly reduced the Ca current stimulated by Iso in the presence of 20 I~M mi- 
crocystin. If we assume that the phosphatase was completely inhibited by microcys- 
tin, this PKC inhibitor could not reduce/ca by inhibiting a kinase.  (d)  In the pres- 
ence of low concentrations of myr-PKC~l~31~ (0.1-0.5  p.M)  that did not completely 
block the basal Ca current, microcystin continued to elevate/ca normally. 
We also tested the effect of calphostin C, which has been reported to selectively 
inhibit PKC in the presence of light (Kobayashi, Nakano, Morimoto, and Tamaoki, 
1989;  Bruns, Miller, Merriman,  Howbert, Heath, Kobayashi, Takahashi, Tamaoki, 
and Nakano, 1991). External application of 0.3-1  ~zM calphostin C in the dark had 
no effect on basal /Ca or on stimulation of/Ca by microcystin. However, if the cell 
was illuminated by the microscope lamp at moderate intensity in the presence of 
0.3 p~M calphostin C,/Ca stimulated by microcystin and Iso was irreversibly and com- 
pletely blocked within 1 min. Because inhibition of the kinase should have no effect 
on the stimulated current after the protein phosphatase is inhibited with microcys- 
tin, we conclude that calphostin C blocks Ica by a mechanism that does not involve 
protein kinase inhibition  (Hartzell and Rinderknecht, manuscript in preparation). 
It seems unlikely that PKX is regulated by Ca, because our internal solution is de- 
signed to buffer Ca to <10 nM.  However, the experiments above utilized  10 mM 
EGTA as the internal Ca buffer, but it is clear that EGTA does not control internal 
Ca concentration on a fast time scale in these cells (cf. Argibay et al., 1988). Conse- 
quently, several experiments were done to test whether PKX might be Ca-regulated 
by buffering Ca with  the  faster chelator,  BAPTA.  In Fig.  5  B,  5  mM BAPTA was 
added to our standard internal solution with no added Ca, and the cell was depo- 
larized only once per minute, rather than once per 8 s as in the other figures, to re- 
duce Ca influx. Under these conditions, internal perfusion with 20 p.M microcystin 
increased Ic~ with the same time course and to the same extent as under our stan- 
dard  conditions.  This  result,  coupled with  the  finding  that the  pseudo-substrate 
peptide inhibitor of CaM-Kinase II had  no effect (data not shown),  suggests that 
PKX is not regulated by Ca. 
In summary, interpretation of experiments with PKC inhibitors was complicated 
by what we interpret as direct effects of PKC inhibitors on Ca channels or nonspe- 
cific effects on the membrane. In these cells, we found no evidence for an effect of 
PKC on /Ca- Further evidence to support this contention is the observation that the 
PKC activators TPA (0.1 p.M) and indolactam-V (0.1 IxM) had no effect on  ]Ca (data 
not shown). 
PKX and PKA Phosphorylate Different Sites 
The data above show that there are two different protein kinases that can elevate 
/ca. Next we wanted to know whether these two kinases phosphorylated the same or 404  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  ￿9  VOLUME  106  ￿9  1995 
different sites. At maximal concentrations,  the  effects of Iso and  microcystin are 
not additive, but the two together do produce a larger response than either alone 
(Fig.  3  B).  To examine further whether  the  two kinases  phosphorylate  different 
sites, we compared the  effects of protein  phosphatase  inhibitors  on basal Ica and 
Iso-stimulated Ica. We found that low concentrations of protein phosphatase inhibi- 
tors that did not stimulate basal/Ca nevertheless could partially subdue the ability of 
ACh to inhibit Iso stimulation of/ca. This result is shown for microcystin in Fig. 6 A. 
In this experiment, the cell was first exposed to Iso, which stimulated Ica ~14-fold, 
and then Iso +  ACh, which reduced Ica tO basal levels. Afterwards, 0.5 IxM microcys- 
tin was perfused internally. In this cell, this concentration of microcystin had no ef- 
fect on basal Ica after ~10  min.  Subsequent  Iso application  stimulated  Ica to the 
same  level  as  before.  Nevertheless,  when  ACh  was  added,  /Ca was  reduced  only 
~50%.  In the presence of Iso and ACh, Ica amplitude was  1 nA with microcystin, 
compared to 200 pA without microcystin. Thus, the inhibition  of the effect of Iso 
by ACh was more sensitive to microcystin than was basal Ic~. Fig. 6 B shows a control 
experiment where the cell was exposed to Iso and Iso+ACh twice separated by 15 
min as in Fig. 6 A. In both cases, ACh completely inhibited the Iso response. The 
purpose of this experiment was to show that the partial inhibition of Iso-stimulated 
Ic~ by the second ACh exposure was not due to desensitization of muscarinic recep- 
tors or some time-dependent rundown of the muscarinic signal transduction  path- 
ways. The time course of the effect of ACh is analyzed for another cell in Fig. 6  C. 
The decrease in /Ca produced by ACh was fitted to a single exponential. In the ab- 
sence of microcystin Ica declined with "r =  3.15 min, whereas in the presence of mi- 
crocystin the decline was somewhat faster, T =  1.75 min. For comparison, the time 
course of the increase in Ica produced by Iso is also shown ('r =  0.83 rain). 
The effects of protein phosphatase inhibitors were analyzed more quantitatively 
using  calyculin  A  (Ishihara,  Martin,  Brautigan,  Karaki,  Ozaki,  Kato,  Fusetani, 
Watabe, Hashimoto, Uemura, and Hartshorne,  1988).  Because calyculin A, unlike 
microcystin, can be applied extracellularly,  dose-response curves are easier to ob- 
tain. Fig. 7 A shows that 30 nM calyculin A had no effect on basal/ca but rendered 
the  stimulation  of /Ca  by Iso  partly irreversible.  A  second  application  of Iso  in- 
creased  the  current  to  the  same  level  as  the  initial  stimulation,  and  the  second 
washout  caused  the  current  to  decline  to  the  same level as  the  first application. 
Concentrations of calyculin A >30 nM alone often stimulated basal/ca. In Fig. 7 B, 
100 nM stimulated/Ca approximately eightfold over a period of 15 min. Subsequent 
application of Iso stimulated Ica in this cell, but often the combination of high con- 
centrations of calyculin and Iso together appeared to be toxic to the cell as the cell 
blebbed and Ica decreased. In Fig. 7 C we plotted the amplitude of/ca stimulated by 
calyculin A alone  (as indicated by the arrow in Fig. 7 B)  (solid  line, circles), the total 
current stimulated by calyculin A and Iso together (solid line, squares),  and the total 
current after Iso had been washed out  10 min  (dashed line,  triangles).  Comparing 
these curves shows that concentrations  of calyculin  <100  nM do not significantly 
increase basal Ic~, whereas they do inhibit the washout of the Iso response. By fit- 
ting the  data  to a  rectangular  hyperbola,  the  EC50 for calyculin  inhibition  of Iso 
washout was 24.6 nM, whereas the ECs0 for stimulation of basal Ica was estimated to 
be 149 nM. HARTZELL ET AL. 
A 
0- 
< 
-soo- 
-1000- 
E 
'~  -1500- 
-2000- 
B 
0- 
"-"  -500  -  .< 
*~  -1000  - 
-1500- 
"d  -2000  - 
r 
-2500  - 
C 
< 
t~ 
Two Phosphorylation  Sites Regulate Ca Current 
ACh  ACh 
Iso  Im 
0,5 uM mieroewtin 
,'0  2'0 
Time (rain) 
95042505.or  8 
3'0  4'0 
ACh 
Iso 
i 
ACh 
Iso 
i 
95042504,org 
10  2'0  3'0  4'0 
Time (min) 
0- 
-1000-  I  ~e 
-2000 -  q~~  ACh with  mieroeystin 
Iso 
-3000- 
94102705.o~ 
Time (min) 
405 
FIGURE 6.  Effects of a  low con- 
centration of microcystin  on  Ic~ 
in  a  ventricular  myocyte.  (A) 
(Open  squares)  Ic~. (Open  circles) 
Holding  current.  Iso  and  ACh 
were applied by superfnsion and 
microcystin was applied by inter- 
nal perfusion for the periods in- 
dicated.  (B) Control cell not per- 
fused with microcystin.  This ex- 
periment  shows  that  repeated 
exposure  to  Iso  and  ACh  pro- 
duce similar effects during a  40- 
min  experiment.  (C)  Fits  of 
changes in Ic,~ in response to Iso 
and ACh. The changes in/Ca pro- 
duced by Iso (crosses), ACh in the 
presence  of  Iso  (squares),  and 
ACh in  the presence of Iso and 
microcystin  (triangles)  were  fit- 
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FIGURE 7.  Effects of the protein 
phosphatase  inhibitor  calyculin 
A on Ica in a ventricular myocyte. 
(A)  Patch clamp record showing 
effect  of a  low  concentration  of 
calyculin  A.  (Open  squares) Ic,. 
(Open  circles)  Holding  current. 
Both Iso and calyculin A were ap- 
plied by superfusion as indicated. 
(B) Patch clamp record showing 
effect of a  high concentration  of 
calyculin  A.  (C)  Dose  response 
curve for the effect of calyculin A 
on  Ica.  (Circles)  Ica density stimu- 
lated by calyculin A  alone  (mea- 
sured  as  shown  by  double- 
headed arrow in B).  (Squares) lea 
density in the presence of calycu- 
lin and Iso.  (Triangles) Ic~, density 
in the presence of calyculin A  af 
ter  washing  out  1  [xM  Iso  (as 
shown in A). Data were  fitted  to 
rectangular  hyperbolas  (lines). 
The best-fit parameters were: caly- 
culin +  Iso: K1/2 =  6.0 nM, Im,x : 
43 pA/pF;  wash  lso: K1/2 =  24.6 
nM,  /~  ....  =  46  pA/pF;  calyculin 
alone:  K1/2 =  149 nM,  /,i,~  =  45 
pA/pF. Data points are means of 
3--13 cells. 
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DISCUSSION 
Conclusions 
(a) The stimulation of/ca by high concentrations of microcystin is due to inhibition 
of a protein phosphatase that dephosphorylates site (s) phosphorylated by a basally 
active protein kinase. This protein kinase is not protein kinase A, because it is not 
blocked  by PKA inhibitor peptides,  and  is  probably not  PKC,  because  it  is  not 
blocked by PKC inhibitor peptides. In the case of PKA inhibitors, we had the posi- 
tive control that these inhibitors blocked the increase in/ca produced by Iso or for- 
skolin. In the case of the PKC inhibitors, although we had no positive controls, we 
do not think PKC is involved because three different PKC inhibitor peptides had 
no effect and we were unable to stimulate/Ca with PKC activators. The kinase is also 
unlikely to be calmodulin-kinase II because free Ca  2+ is buffered to <10 -9 M. Thus, 
it appears  that the increase in /Ca produced by microcystin involves phosphoryla- 
tion by a novel protein kinase (PKX). We are confident that the effect of microcys- 
tin on/Ca is, indeed, due to a protein kinase and not to some other effect of micro- 
cystin  (as described below for IK) because the effect of microcystin requires ATP 
(Frace and HartzeU, 1993) and is blocked by two protein kinase inhibitors, stauro- 
sporine and K252a. 
(b)  The regulation of the Ca channel involves phosphorylation of two different 
sites.  The observation that low concentrations of microcystin or calyculin A  only 
partially block the washout of Iso  (Figs. 6 and 7)  suggests that the effect of Iso in- 
volves phosphorylation of two different sites or involves two different mechanisms. 
We prefer the conclusion that Iso stimulates cAMP-dependent phosphorylation of 
two different sites because the effect of Iso is completely blocked by inhibitors of 
PKA (Hartzell et al., 1991). Furthermore, it is unlikely that the fraction of/Ca stimu- 
lation that is reversible in the presence of low concentrations of microcystin is due 
to a direct G protein effect (Brown and Birnbaumer,  1990)  because high concen- 
trations of microcystin completely block the washout of the Iso effect. From Fig. 7 
C, it appears that N50% of the sites are sensitive to low concentrations of calyculin, 
although scatter in the data make a precise quantification difficult. The existence 
of two sites is also supported by the observation that high concentrations of micro- 
cystin stimulate basal/ca. The site that is phosphorylated by PKX and responsible 
for this increase in basal/ca may be the same site phosphorylated by PKA with low 
sensitivity to microcystin or calyculin A. The idea of two different phosphorylation 
sites  regulating  Ca  channel  availability and  gating  was  first proposed  by Tsien, 
Bean, Hess, Lansman, Nilius, and Nowycky (1986).  More recently, single-channel 
analysis by Herzig,  Patil,  Neumann,  Staschen,  and Yue  (1993)  and  by Ono and 
Fozzard (1993) have provided more direct experimental support for this idea (see 
below). 
(c) The effect of microcystin on the delayed rectifier current IK does not seem to 
be mediated by a protein kinase that is sensitive to either staurosporine or K252a. 
Although the possibility still exists that the inhibition of IK by microcystin is due to 
inhibition of a protein phosphatase,  this seems unlikely for several reasons. First, 
the effect of microcystin on IK is considerably faster than the effect on/ca (Fig. 1 B). 
We think that the rate of decrease in IK is related to the time it takes for microcystin 408  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  "  VOLUME  106  ￿9  1995 
to equilibrate with the cell contents, whereas the increase in/ca reflects the rate of 
phosphorylation. Also, in our previous paper (Frace and Hartzell, 1993) we showed 
that the effect of microcystin on/ca required ATP  (which suggested the role of a 
protein kinase), but we were unable to test this for IK because IK disappeared when 
the cell was perfused internally with ATP-free solutions. Thus, we have no reason to 
believe that a protein kinase is involved and hypothesize that the effect of microcys- 
tin may be due to a direct effect on the delayed rectifier channel. Because a chemi- 
cally unrelated protein phosphatase inhibitor, okadaic acid, produces the same ef- 
fect (Frace and Hartzell, 1993), the hypothetical binding site on the K channel may 
share some similarity with the protein phosphatases. 
Kinetic model ofphosphorylation  and dephosphorylation. If we assume that the am- 
plitude of/ca is proportional to the concentration of a  phosphorylated substrate 
(either the Ca channel itself or a regulator of the channel), then our data is consis- 
tent with the model shown in Fig. 8. The substrate can be phosphorylated by PKA 
dephosphowlated  t 
k2 (PKX) I  k-2 (PPase) 
phosphorylated (2) 
kl (PKA) 
k-1 
(PPase  2A) 
k3 (PKA) 
k-3 (PPase) 
D,  phosphorylated (1) 
v 
k-4 (PPase) TI k4  (PKX,PKA) 
phospho~ated (1+2) 
FIGURE 8.  Model of regulation of/ca by phosphorylation. It is assumed that a single substrate is the 
target of PKA and PKX. This substrate may be the Ca channel or another regulatory protein. The 
substrate can be phosphorylated on two different sites independently by PKA and PKX. Each site is 
dephosphorylated by a protein phosphatase  (PPase). 
(at rate kl)  or PKX (at rate k~) to give singly phosphorylated states or can be phos- 
phorylated by both kinases (via k~ and k~ or via k] and k4). We believe that in the ab- 
sence of B-receptor stimulation, that PKA activity is very low (kl and k~ very small), 
because inhibition of PKA has no effect on basal/ca  (Fig.  1 C, see also Hartzell et 
al., 1991). In contrast PKX does exhibit basal activity because inhibition of dephos- 
phorylation (k_~) with microcystin causes/ca to increase and because inhibition of 
PKX with K252a or staurosporine causes a 40-50% decrease in basal/ca. Thus, un- 
der basal conditions, we hypothesize that most of the substrate exists in the dephos- 
phorylated state but a small fraction is in the phosphorylated (2) state. Upon appli- 
cation of microcystin most of the substrate is converted to the phosphorylated (2) 
state, but very little exists in the doubly phosphorylated state [phosphorylated (1 + 
2) ] because PKA inhibitors have little or no effect on the increase in/ca produced 
by microcystin and because Iso usually increases Ic~ further beyond that produced HARTZELL Vn" AL.  Two Phosphorylation Sites Regulate Ca Current  409 
by microcystin alone. Application of Iso alone converts the substrate to the phos- 
phorylated  (1)  state  and  the  phosphorylated  (1  +  2)  state.  We  do  not  know 
whether phosphorylafion of site 2 in the presence of Iso is actually catalyzed by PKA 
or PKX. PKA might phosphorylate both sites 1 and 2, but because PKX is basally ac- 
five, one might also expect a  certain proportion of the substrate to be phosphor- 
ylated both by PKA and PKX in the presence of Iso. It is also possible that the rate 
constants  h~ and k4 are different, such  that a  substrate phosphorylated by PKA is 
phosphorylated more rapidly by PKX or that PKX activity itself is regulated by PKA 
phosphorylation. The results of Figs. 6 and 7 show, however, that in the presence of 
Iso, two sites with different sensitivities to phosphatase  inhibitors are phosphory- 
lated. Our finding that K252a reduces Iso stimulated current could be interpreted 
in two ways:  either K252a is nonselective for PKX and PKA or K252a reduces Iso- 
stimulated  Ic~ because PKX-mediated phosphorylafion comprises 25%  of the Iso- 
stimulated increase in/Ca. Although this second alternative is a possibility, K252a is 
known to inhibit PKA in vitro with an ICs0 of N20 nM (Kase et al., 1987). 
Relative rates of  phosphorylation  by PKA and PKX.  We would  like  to know how 
the rates of phosphorylation by PKX and PKA compare, because if the rate of PKX- 
mediated phosphorylation is similar to PKA activity, this might suggest that PKX 
has a  significant physiological role on basal  Ic~. Conversely, if the activity is very 
small, it might suggest that PKX is not physiologically important unless it is regu- 
lated. We can estimate kl and k2 in Fig. 8 if we make some simplifying assumptions. 
First, we assume that Iso increases only kl. This is justified by the finding that PKA 
inhibitors completely block the response to Iso  (Hartzell et al.,  1991). We also as- 
sume that k~ is the rate-limiting step in the increase in/Ca produced by Iso. This as- 
sumption is less secure. We have previously shown that the rate-limiting step is sub- 
sequent to cAMP production, although we have not shown that the rate-limiting 
step is the phosphorylation itself (Frace, M&y, Fischmeister, and Hartzell, 1993). 
For example, if PKA phosphorylates a regulator of the Ca channel rather than the 
Ca channel itself, association of the regulator with the channel could be rate-limit- 
ing. Nevertheless, under the assumption that kl is the only rate constant affected by 
Iso and is limiting, kl can be estimated by measuring the rate of/ca increase in re- 
sponse to Iso in the presence of microcystin to reduce k-a to zero. The phosphory- 
lation rate due to PKA was estimated in this manner to be 1.20 _  0.03 min -1  (Fig. 6 
B). It should be noted that the increase in/ca produced by Iso in the presence of 
microcystin and kinase inhibitors was not greatly different (0.7 min -~ for Fig. 2 A), 
which confirms that even if Iso does stimulate phosphorylation by PKX, PKX phos- 
phorylation is not rate-limiting. To estimate k2, we assume that PKA is inactive in 
the absence of Iso (as shown by the insensitivity of the increase in/ca caused by mi- 
crocystin to PKA inhibitors, Fig. 1 C) and that the increase in Ic~ in response to mi- 
crocystin is due solely to phosphorylation via k2. If microcystin reduces k_~ to zero, 
then the rate of increase in/ca in response to microcystin will be a lower estimate of 
k2. The average was 0.13 _  0.03 min -a, but in some cells the rate was as high as 0.43 
min-L Thus, the rate of phosphorylation by PKX may be between 10 and 35% of 
the rate of PKA phosphorylation in the presence of a maximally stimulating dose of 
Iso. These calculations support the view that PKX activity is sufficiently high to be 
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Which protein phosphata3es are involved?  In cell-free systems, microcystin inhib- 
its protein phosphatase 1 and 2A with a Ki of 0.1 nM, protein phosphatase 2B with 
a Ki of 0.2/zM, and protein phosphatase 2C with a Ki >10/zM  (Honkanen et al., 
1990; MacKintosh et al., 1990). Calyculin A inhibits phosphatase 1 and 2A with a Ki 
of 1-2 nM (Ishihara et al., 1988). In our experiments, the washout of Iso was par- 
tially inhibited by 0.1-1/zM microcystin and 5--30 nM calyculin A. This is in a range 
consistent with the involvement of either type 1 or 2A phosphatases. Because inter- 
nal  perfusion with the  regulatory subunit of protein phosphatase  1  (Inhibitor-2, 
Cohen, 1989) had no effect on Iso washout (not shown) and because protein phos- 
phatase 2B was inhibited by buffering internal Ca  2+ to <1 nM, we suggest that pro- 
tein phosphatase 2A may be the major contributor to dephosphorylation of site 1. 
Stimulation of basal/ca occurred at concentrations of microcystin > 1 I-~M and ca- 
lyculin >30 nM. These concentrations are quite high relative to the Ki for inhibi- 
tion  of either type  1  or type 2A phosphatase.  Other candidates for the  protein 
phosphatase are phosphatase 2B (calcineurin), phosphatase 2C, and other unchar- 
acterized protein phosphatases. Calcineurin does not seem to be a likely candidate, 
because it should not be active under conditions where intracellular Ca is buffered 
by BAPTA (Fig. 5 B) and because calcineurin inhibitor peptides had little effect on 
basal Ica (Frace and Hartzell, 1993). Protein phosphatase 2C exhibits a dependence 
on Mg  2+  in  the  1-10 mM  range  (Cohen,  1989).  We have previously shown  that 
changes in internal free Mg  2+ in the range of 0.3 to 3 mM modulate the response 
of/Ca to Iso by a  mechanism which could involve protein phosphatase  2C  (White 
and Hartzell, 1988; Hartzell and White, 1989). Unfortunately, protein phosphatase 
2C does not appear to be inhibited by microcystin at concentrations as high as 4 
p~M  (MacKintosh et al.,  1990). Thus, it appears that the phosphatase inhibited by 
high  concentrations of microcystin in  our studies  may be  a  novel protein phos- 
phatase. 
Another issue relevant to the effect of microcystin is the observation that in this 
series of experiments, conducted from September, 1994, until May, 1995, the ap- 
parent potency and efficacy of microcystin were less than we observed in earlier ex- 
periments done between 1989 and  1993  (Frace and Hartzell, 1993). For example, 
in the present experiments 0.5 ~M microcystin had no effect on basal /Ca, whereas 
previously this concentration produced a severalfold increase in/Ca.  10 p.M micro- 
cystin in the present experiments produced a  10-fold increase in Ica; previously it 
produced a  19-fold increase. This lower efficacy was found in five different lots of 
microcystin from two manufacturers, but unfortunately we have no samples of the 
microcystin from 1993 to compare. 
Comparison to other studies.  Some limited comparisons can be made  to other 
studies.  In  their  studies  on  the  mammalian  cardiac  Ic~, Hescheler,  Kameyama, 
Trautwein, Mieskes, and S61ing (1987) and Hescheler, Mieskes, Ruegg, Takai, and 
Trautwein  (1988)  have  shown  that  50  p.M  okadaic  stimulated  basal  /ca  approxi- 
mately twofold. Although there were no data presented as to the nature of the ki- 
nase responsible for this increase, it seems possible that the stimulation of basal/Ca 
was due to a kinase analogous to our PKX. However, their results differ from ours 
in that the washout of Iso stimulation was only slowed two- to threefold but was not 
prevented by okadaic acid. In addition, inhibitor-2 enhanced the stimulation by Iso HARTZELL ZT AL.  Two Phospho~ylation Sites Regulate Ca Current  411 
and slowed washout of the Iso effect twofold, suggesting a role for protein phos- 
phatase-1 in this cell type. However, phosphatase 2A is probably also involved be- 
cause okadaic acid, which inhibits both phosphatase 1 and 2A at the concentrations 
used had a larger effect than inhibitor-2 which inhibits only phosphatase-1. 
Recently, Ono and Fozzard (1993)  showed that in cell-attached patches of rabbit 
ventricular myocytes, concentrations of okadaic acid  <1  o~M increased channel 
availability,  whereas  high  concentrations  (>10  I~M) of okadaic  acid  increased 
channel open time. These authors conclude that there are two  phosphorylation 
sites that regulate the Ca channel. One of these sites controls channel availability 
and  the  other controls  channel open  time.  From the  analysis  by Herzig et al. 
(1993),  channel availability probably corresponds to channel gating mode 0a,  1, 
and 2. 
Somewhat analogous results have been obtained by Hwang, Horie, and Gadsby 
(1993)  in their analysis of the regulation of the PKA-regulated C1 current in mam- 
malian heart. They have found that the C1 channel is phosphorylated by PKA at two 
sites that have differing sensitivities  to protein phosphatase inhibitors. Thus, multi- 
ple phosphorylation by protein kinases may be a common feature of ion channels. 
However, in contrast to the stimulation of basal/Ca by microcystin, the basal C1 cur- 
rent is not stimulated by okadaic acid or microcystin alone which suggests that the 
C1 channel may not be regulated by PKX-like kinases. 
Identity of  PKX.  We have not yet identified PKX, except to conclusively rule 
out PKA. The next most attractive candidate, PKC, has been difficult to rule out be- 
cause the inhibitors that are available for PKC have been problematic. The most se- 
lective inhibitors, the pseudosubstrate peptides, have no effect when applied by in- 
ternal perfusion in our system. Inhibitors applied extracellularly, such as the myris- 
toylated pseudosubstrate peptide, sphingosine, and calphostin C had nonspecific 
effects that were clearly not related to their ability to block protein kinase C. These 
studies, which we will publish in detail elsewhere, underscore the problems with 
the selectivity of many protein kinase C inhibitors. Nevertheless, it is unlikely that 
PKC is not PKX because of the absence of effect of the pseudosubstrate peptide in- 
hibitors and the lack of effect of protein kinase C stimulators. 
Physiological sign~cance.  The physiological significance of phosphorylation by 
PKX remains to be determined. However, the fact that basal/Ca is reduced 40-50% 
by K252a suggests that PKX may play a role in setting the amplitude of basal/Ca. We 
have previously reported (Argibay, Fischmeister, and Hartzell, 1988)  that basal/ca 
density in frog ventricular myocytes is extremely variable  (from 1.3 pA/pF to 28 
pA/pF). It is possible that this variability reflects the basal level of phosphorylation 
by PKX. If this is the case, one would predict that the degree of inhibition of basal 
/ca by K252a would correlate with basal/Ca density, but we do not yet have sufficient 
data to answer this question. However, in some rare dissociations,/Ca in nearly every 
cell  increased  spontaneously after  patch  break  severalfold  and  sometimes  ap- 
proached 1 to 2 nA in amplitude. What stimulated this increase is unknown. Never- 
theless, in two cells with a spontaneously-elevated current of >1 nA, application of 
250  nM K252a  rapidly returned/ca to ~100 pA, suggesting that the increase was 
caused by activation of PKX. Subsequent application of Iso produced a normal in- 
crease. This observation raises two questions: is protein kinase X regulated by neu- 412  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  ￿9  VOLUME  106  ￿9  1995 
rotransmitters  or  hormones?  Can  disorders  of  this  PKX  produce  pathological 
states? 
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